Cargando…
Proposed mechanism for rare thrombotic events after use of some Covid-19 vaccines
Administration of AstraZeneca/Oxford and Johnson & Johnson/Janssen Covid-19 vaccines which use an adenovirus vector for DNA delivery has been associated with very rare thromboembolic complications coupled with an immune response to platelet factor 4 protein. The cause of this has not yet been id...
Autor principal: | Feldman, Peter A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8722443/ https://www.ncbi.nlm.nih.gov/pubmed/35002021 http://dx.doi.org/10.1016/j.mehy.2021.110756 |
Ejemplares similares
-
Thrombotic events and COVID-19 vaccines
por: Brazete, C., et al.
Publicado: (2021) -
Autoimmunity roots of the thrombotic events after COVID-19 vaccination
por: Elrashdy, Fatma, et al.
Publicado: (2021) -
An Update on the Pathogenesis of COVID-19 and the Reportedly Rare Thrombotic Events Following Vaccination
por: Kantarcioglu, Bulent, et al.
Publicado: (2021) -
Spotlight on Adenovirus-Based Vaccines and Rare Thrombotic Events
por: Chirumbolo, Salvatore
Publicado: (2021) -
Thrombotic events following Covid-19 vaccines compared to Influenza vaccines
por: Vallone, Marcelo Gabriel, et al.
Publicado: (2022)